Global Idiopathic Pulmonary Fibrosis Drugs and Companies Pipeline Review H1 2016
Summary
Global Markets Directs, Idiopathic Pulmonary Fibrosis - Pipeline Review, H1 2016, provides an overview of the Idiopathic Pulmonary Fibrosis pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Idiopathic Pulmonary Fibrosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Idiopathic Pulmonary Fibrosis and features dormant and discontinued projects.
Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources.
Download free Sample PDF report with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=724169
Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.
Scope
- The report provides a snapshot of the global therapeutic landscape of Idiopathic Pulmonary Fibrosis
- The report reviews pipeline therapeutics for Idiopathic Pulmonary Fibrosis by companies and universities/research institutes based on information derived from company and industry-specific sources
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
Read All Pharmaceutical Market Research Reports @ http://www.researchmoz.us/pharmaceutical-market-reports-38.html
Table of Contents
Table of Contents 2
List of Tables 6
List of Figures 8
Introduction 9
Global Markets Direct Report Coverage 9
Idiopathic Pulmonary Fibrosis Overview 10
Therapeutics Development 11
Pipeline Products for Idiopathic Pulmonary Fibrosis - Overview 11
Pipeline Products for Idiopathic Pulmonary Fibrosis - Comparative Analysis 12
Idiopathic Pulmonary Fibrosis - Therapeutics under Development by Companies 13
Idiopathic Pulmonary Fibrosis - Therapeutics under Investigation by Universities/Institutes 17
Idiopathic Pulmonary Fibrosis - Pipeline Products Glance 18
Clinical Stage Products 18
Early Stage Products 19
Idiopathic Pulmonary Fibrosis - Products under Development by Companies 20
Idiopathic Pulmonary Fibrosis - Products under Investigation by Universities/Institutes 25
Idiopathic Pulmonary Fibrosis - Companies Involved in Therapeutics Development 26
AdAlta Pty Ltd. 26
About ResearchMoz
ResearchMoz is the worlds fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMozs service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.
Contact Us:
Mr. Nachiket
Albany NY - 12207
United States
Tel: +1-518-621-2074
Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Follow us on LinkedIn at: http://bit.ly/1TBmnVG